rs121964968
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong
The NM_000071.3(CBS):c.1616T>C(p.Leu539Ser) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000071.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 0
GnomAD4 exome Cov.: 0
GnomAD4 genome Cov.: 0
ClinVar
Submissions by phenotype
Homocystinuria, pyridoxine-responsive Pathogenic:1
- -
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED Pathogenic:1
This sequence change replaces leucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 539 of the CBS protein (p.Leu539Ser). This variant is present in population databases (rs121964968, gnomAD 0.006%). This missense change has been observed in individual(s) with clinical features of homocystinuria due to CBS deficiency (PMID: 8990018). ClinVar contains an entry for this variant (Variation ID: 124). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CBS protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CBS function (PMID: 20506325). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Homocystinuria Pathogenic:1
Variant summary: CBS c.1616T>C (p.Leu539Ser) results in a non-conservative amino acid change located in the Cystathionine beta-synthase, C-terminal domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250168 control chromosomes (gnomAD). c.1616T>C has been reported in the literature in at least one individual affected with Homocystinuria (Aral_1997). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity (Kozich_2010, Melenovska_2015). The following publications have been ascertained in the context of this evaluation (PMID: 20506325, 25331909, 8990018). ClinVar contains an entry for this variant (Variation ID: 124). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Classic homocystinuria Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at